ELIZABETH DONG NGUYEN
Medical Practice at Sand Point Way, Seattle, WA

License number
Washington ML60561467
Category
Medical Practice
Type
Pediatrics
Address
Address
4800 Sand Point Way NE OC.7.830, Seattle, WA 98105
Phone
(206) 987-2525

Personal information

See more information about ELIZABETH DONG NGUYEN at radaris.com
Name
Address
Phone
Elizabeth Nguyen
5312 S Hazel St, Seattle, WA 98178
Elizabeth Nguyen
9104 211Th Street Ct E, Graham, WA 98338
Elizabeth Nguyen, age 54
1908 Walker St, Seattle, WA 98144
Elizabeth Nguyen, age 80
18100 142Nd Ave NE, Woodinville, WA 98072
Elizabeth Nguyen
14211 7Th Way, Vancouver, WA 98683

Professional information

Elizabeth Nguyen Photo 1

Accountant At Pemco Technology Services Inc.,

Position:
Accountant at Pemco Technology Services Inc.,
Location:
Greater Seattle Area
Industry:
Accounting
Work:
Pemco Technology Services Inc., - Accountant
Education:
DePaul University 1987 - 1991


Elizabeth Nguyen Photo 2

Independent Banking Professional

Location:
Greater Seattle Area
Industry:
Banking


Elizabeth Nguyen Photo 3

Contract Specialist At Western Regional Medical Command

Position:
contract specialist at western regional medical command
Location:
Greater Seattle Area
Industry:
Defense & Space
Work:
western regional medical command - contract specialist


Elizabeth Nguyen Photo 4

Methods Of Isolating Amyloid-Inhibiting Compounds And Use Of Compounds Isolated From Uncaria Tomentosa And Related Plants

US Patent:
6929808, Aug 16, 2005
Filed:
Nov 2, 2001
Appl. No.:
10/053625
Inventors:
Gerardo Castillo - Seattle WA, US
Paula Y. Choi - Bothell WA, US
Elizabeth Nguyen - Renton WA, US
Alan D. Snow - Lynnwood WA, US
Assignee:
ProteoTech, Inc. - Kirkland WA
International Classification:
A51K035/78, A61K031/35
US Classification:
424725, 424769, 514456
Abstract:
Assay-guided affinity fractionation and reverse phase high pressure liquid chromatography (HPLC) methodology to isolate, test and characterize the most active water-soluble ingredients within Cat's Claw, or. These components appear to account for the majority of the amyloid or Aβ fibrillogenesis inhibitory activity. Individual fractions and/or compounds as isolated by HPLC are tested in relevant in vitro and/or animal models, and found to consistently demonstrate inhibition of amyloid or Aβ fibrillogenesis. Related extraction methods are disclosed.